Skip to main content
APURES CO., LTD. logo

APURES CO., LTD. — Investor Relations & Filings

Ticker · 149300 ISIN · KR7149300006 KO Professional, scientific and technical activities
Open in API
Filings indexed 196 across all filing types
Latest filing 2025-12-26 Director's Dealing
Country KR South Korea
Listing KO 149300

About APURES CO., LTD.

https://www.apures.com/

APURES CO., LTD. is a biotechnology company specializing in research and development solutions centered on its proprietary "MICROPIG" platform. This internationally registered minipig model, which is anatomically and physiologically similar to humans, serves as a foundation for the company's diverse offerings. APURES develops and supplies standard and transgenic MICROPIG models, along with a portfolio of derived bio-resources including organs, tissues, and standardized primary cells for cell-based assays. The company provides comprehensive non-clinical contract research organization (CRO) services, offering integrated in-vitro and in-vivo testing solutions tailored for new drug development. Additionally, APURES is advancing into therapeutic innovation, developing bio-materials for xenotransplantation and tissue engineering, and pursuing the development of its own pipeline of gene therapies.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a formal 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/KRX). It details changes in share ownership by a major shareholder (Medigenetics) in the issuer (Apures). This type of filing is specifically categorized as a 'Director's Dealing' or 'Insider Trading' report in financial databases, as it tracks transactions by major shareholders and insiders.
2025-12-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details changes in share ownership (specifically a decrease due to collateral disposal/margin calls) by a major shareholder (Medi Genetics Co., Ltd.) in the issuer (Apures Co., Ltd.). This falls under the category of Major Shareholding Notification.
2025-12-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure required by the Financial Supervisory Service (FSS) in South Korea when a major shareholder or executive changes their stake in a company. This specific document details the disposal of shares by a major shareholder (Medigenetics Co., Ltd.) in the company Apures Co., Ltd. This falls under the category of 'Director's Dealing' (DIRS) as it reports insider/major shareholder transactions.
2025-12-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Medi Genetics Co., Ltd.) in the company 'Apures'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant changes in ownership levels and voting rights.
2025-12-16 Korean
기업설명회(IR)개최
Investor Presentation Classification · 90% confidence The document is an announcement of an upcoming Investor Relations (IR) event scheduled for November 14, 2025. It details the event's date, time, location, participants, purpose, and agenda, but does not contain any financial data or results. It also states that the IR materials will be posted later on the exchange's disclosure system. The document length is short (993 characters) and serves as a notice rather than the actual investor presentation or report. Therefore, it fits the category of an Investor Presentation announcement rather than the presentation itself. According to the classification rules, this is best classified as an Investor Presentation (IP) since it is about an IR event and its details, not a report publication announcement or regulatory filing.
2025-10-29 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in Korea. It details changes in share ownership by (주)상상인저축은행 in the company 아퓨어스(주) due to the exercise of collateral disposal rights. This type of filing is a standard regulatory requirement for significant shareholding changes (often referred to as the 5% rule or major shareholding notification). Based on the provided definitions, this falls under 'Major Shareholding Notification'.
2025-08-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.